Audio Interviews

N4P ” A little known story ”

07 Mar 2016 | by: James Moore

Today I had a chat with Nigel Theabold CEO of N4 Pharma, the small private company hit the headlines when Aim listed investment company Onzima Ventures announced its investment for 49% of the company. The business works extensively on a number of compounds through the early development stage, with a novel structure which reduces significant dilution whilst focusing on progressing quickly into presenting its products through its technology platform.

  • Business model to reformulate and develop erectile dysfunction drugs
  • Strong background in product development working with Oxford Pharma Science
  • New clinical and commercial products into the forefront of industry
  • Regular focus on news flow with as the exciting outlook surfaces further, Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

    RNS Responses

    What is an alternative investment?

    Alternative investments cover everything from venture capital and commodities to stamps, antiques and even whisky. Find out more in our ‘What is..?’ series.

    Squarespace IPO: what you need to know

    Squarespace $SQSP is heading for a direct listing this month. Does this tech savvy web hosting service look a good long-term investment or a stock to avoid?

    Are there any ESG friendly cryptos?

    Environmental, Social, and Corporate Governance (ESG) investing is forcing agendas. Will Tesla backing out of accepting Bitcoin hinder crypto’s rise?

    What is a SPAC?

    SPAC is short for Special Purpose Acquisition Company – though it’s also sometimes known as a ‘blank cheque company’ – but what exactly is it?